Eversept Partners’s Ortho Clinical Diagnostics Holdings OCDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-445,059
Closed -$8.3M – 105
2022
Q1
$8.3M Sell
445,059
-441,081
-50% -$7.94M 0.64% 41
2021
Q4
$19M Sell
886,140
-28,846
-3% -$568K 1.21% 22
2021
Q3
$16.9M Sell
914,986
-479,298
-34% -$9.7M 1.17% 23
2021
Q2
$29.9M Buy
1,394,284
+19,056
+1% +$387K 1.99% 20
2021
Q1
$26.5M Buy
+1,375,228
New +$24.2M 1.99% 19

Other funds holding OCDX

Eversept Partners's OCDX Position: Q2 2022 in Review

Eversept Partners sold out of Ortho Clinical Diagnostics Holdings (OCDX) in Q2 2022, closing a stake of 445,059 shares — an estimated $8.3M sold.

Eversept Partners first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $29.9M in Q2 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Eversept Partners reported no remaining Ortho Clinical Diagnostics Holdings position as of Q2 2022 after selling out during the quarter.
  • Eversept Partners sold 445,059 Ortho Clinical Diagnostics Holdings shares in Q2 2022, an estimated $8.3M.
  • Eversept Partners first reported a position in Ortho Clinical Diagnostics Holdings in Q1 2021 and held it in 5 quarters.
  • Eversept Partners's Ortho Clinical Diagnostics Holdings position peaked at $29.9M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings as of Q2 2022.

Based on Eversept Partners's 13F filing for Q2 2022, filed 15 Aug 2022.